Company: INTS
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001567264-25-000039
Chunk: 10

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part II, Item 3
Chunk 10
---
 authorized.

Intensity Therapeutics, Inc.Date: May 13, 2025By:/s/ Lewis H. BenderLewis H. BenderPresident, Chief Executive Officer and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate/s/ Lewis H. BenderPresident, Chief Executive Officer and ChairmanMay 13, 2025Lewis H. Bender(principal executive officer)/s/ Joseph TalamoChief Financial OfficerMay 13, 2025Joseph Talamo(principal financial officer)

25